NeuroNova AG

NeuroNova AG is a Munich based biopharmaceutical company developing novel drugs for the treatment of depression and anxiety. We have identified, validated numerous innovative targets that will lead to the discovery of entirely new classes of fast acting antidepressants and anxiolytics. In addition, the company has extensive expertise in behavioral pharmacology and has exclusive models for the preclinical testing of drug candidates.

Details


Adresse:
NeuroNova AG

Kraepelinstr. 2
80804 München
Deutschland
Arbeitsgebiet:
Forschung & Lehre
Expansion:
national
Webseite:
Mitarbeiteranzahl:
11-50
Gründungsjahr:
2002